---
title: "Cutting Pharmaceutical Waste and Stockouts at the Same Time with RL"
date: "2026-06-08"
excerpt: "Pharmaceutical inventory sits at the intersection of expiry-date pressure and unpredictable demand. A hybrid deep RL approach shows it's possible to reduce cost and maintain patient service levels simultaneously — and here's what that means for hospital pharmacies and distributors."
image: "/column-images/pharmaceutical-inventory-rl-dynamic-replenishment.png"
imageAlt: "A flat illustration abstractly depicting an AI managing pharmaceutical replenishment cycles"
readingMinutes: 5
basedOnPaper: "Learning to replenish: A hybrid deep RL for dynamic inventory management in pharmaceutical supply chains"
basedOnPaperUrl: "https://arxiv.org/abs/2606.06201"
---

Hello. This is Keito Inoshita from Affectosphere Group.

Pharmaceutical inventory management carries a tension that ordinary retail does not face.

On one side: disposal costs from expired medications. Specialty drugs and biologics can run tens of thousands of yen per vial. Throwing them out is a significant financial hit.

On the other side: patient impact from stockouts. Run inventory too lean and the drug someone needs simply isn't there. That is a direct medical risk, not just a logistics problem.

Optimizing both simultaneously — that is the core challenge of pharmaceutical inventory management.

A study published on arXiv in June 2026 (Amandeep Kaur, Gyan Prakash, arXiv:2606.06201) proposes addressing this with reinforcement learning. The results are worth paying attention to.

---

## Three takeaways for today

1. Framing pharmaceutical inventory as a Markov Decision Process and using a hybrid A3C-DPPO deep RL algorithm produces learnable replenishment policies that outperform classical approaches.
2. Validation on real pharmaceutical data showed cost reduction while maintaining patient service levels — breaking the usual waste-vs-stockout tradeoff.
3. High-cost, short-shelf-life specialty medications represent the most compelling ROI case for RL-based replenishment engines.

---

## ① How the researchers framed the problem

The interesting methodological move in this study is how the problem is set up.

Inventory management is formulated as a Markov Decision Process — observe the current inventory state, choose a replenishment action, and learn from reward signals that penalize both disposal loss and stockouts. This framing has been used before, but what this research adds is simultaneously modeling expiry-date penalties and demand variation from seasonal and sudden shifts.

Different drugs expire at different rates. Demand varies sharply with seasons and disease outbreaks. Both constraints are built into the model before training begins.

The algorithm combines A3C (Asynchronous Advantage Actor-Critic) and DPPO (Distributed Proximal Policy Optimization) in a hybrid architecture. A3C excels at efficient exploration across diverse states; DPPO provides stable, reliable convergence. Pharmaceutical inventory management needs both — it is a complex optimization problem with many interacting variables.

---

## ② How much difference did it make on real data?

The study's most important feature is validation on actual pharmaceutical data rather than synthetic scenarios.

Against competing approaches, the hybrid RL method reduced inventory cost while maintaining patient service levels — the probability that a needed medication is available when needed. The specific numbers are in the paper, but the structural point matters: the waste-stockout tradeoff was not just shifted in one direction, it was improved on both dimensions simultaneously.

Why can RL do this when fixed-rule replenishment models struggle?

Fixed safety stock rules set a buffer value that does not change unless someone reconfigures it manually. RL continuously learns from observed demand patterns. It adjusts how much inventory to hold based on current season, current demand trajectory, and remaining shelf life — dynamically, without manual intervention.

"Situation-dependent judgment" is exactly the capability that rule-based systems lack and that learning-based approaches can provide.

---

## ③ ROI thinking for hospital pharmacies and distributors

Where does this approach generate the most compelling return on investment in practice?

Three categories stand out.

First: high-cost, short-shelf-life specialty drugs. Biologics, oncology medications, and rare-disease treatments are the obvious targets. A single disposal event is expensive; demand is hard to predict; the RL advantage is greatest here.

Second: highly seasonal items — flu treatments, antihistamines, and anything tied to disease cycles. Seasonal demand waves exceed what fixed models can absorb smoothly. A learning-based model adapts continuously.

Third: network-level inventory optimization across multi-site hospital groups or pharmacy chains. Inter-facility inventory transfer decisions are a natural extension of the same approach.

For a first implementation, the realistic path is adding an RL-based replenishment recommendation engine as an API layer on top of existing hospital information systems or warehouse management systems, with pharmacists retaining final order approval. This keeps the human in the loop while capturing the optimization benefit.

KPIs to track in parallel: expired disposal cost (monthly), stockout rate, and inventory turnover ratio. All three need to move together to confirm the model is actually delivering on both sides of the tradeoff.

---

## From static buffers to dynamic replenishment

Pharmaceutical inventory has been managed with the "safety stock" concept for decades — set a fixed buffer against uncertainty, reorder when you drop below it. Simple and robust, but not adaptive.

RL-based replenishment represents a shift in paradigm: instead of a fixed buffer, dynamically adjust how much to hold based on current demand patterns, shelf-life distribution, and inventory status.

This research sits at the intersection of RL methodology and a very concrete operational pain point. For hospital pharmacy directors and pharmaceutical distribution teams thinking about where AI delivers practical value, it is a meaningful data point.

That's it for today!

---

## Reference

1. Amandeep Kaur, Gyan Prakash (2026). *Learning to replenish: A hybrid deep RL for dynamic inventory management in pharmaceutical supply chains*. arXiv preprint.

<p class="ai-notice"><small>* This article was written in part with AI assistance and may contain inaccuracies.</small></p>
